Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres

Background

Despite the widespread availability of biological drugs in psoriasis, there is a shortage of disease burden studies.

Objectives

To assess the cost-of-illness and quality of life of patients with moderate to severe psoriasis in Hungary.

Methods

Consecutive patients with Psoriasis Area and Severity Index (PASI) > 10 and Dermatology Life Quality Index (DLQI) > 10, or treated with traditional systemic (TST) or biological systemic treatment (BST) were included. Demographic data, clinical characteristics, psoriasis related medication, health care utilizations and employment status in the previous 12 months were recorded. Costing was performed from the societal perspective applying the human capital approach. Quality of life was assessed using DLQI and EQ-5D measures.

Results

Two-hundred patients were involved (females 32 %) with a mean age of 51 (SD 13) years, 103 (52 %) patients were on BST. Mean PASI, DLQI and EQ-5D scores were 8 (SD 10), 6 (SD 7) and 0.69 (SD 0.3), respectively. The mean total cost was €9,254/patient/year (SD 8,502) with direct costs accounting for 86 %. The main cost driver was BST (mean €7,339/patient/year). Total costs differed significantly across treatment subgroups, mean (SD): no systemic therapy €2,186 (4,165), TST €2,388 (4,106) and BST €15,790 (6,016) (p < 0,001). Patients with BST had better PASI and DLQI scores (p < 0.01) than the other two subgroups.

Conclusions

Patients with biological treatment have a significantly better quality of life and higher total costs than patients with or without traditional systemic treatment. Our study is the largest in Europe and the first in the CEE region that provides cost-of-illness data in psoriasis involving patients with BST.

     

Multiple mitochondrial DNA deletions and persistent hyperthermia in a patient with Brachmann-de Lange phenotype

In a newborn boy with characteristics of Brachmann-de Lange syndrome (BDLS) high temperatures were observed on the second day after birth and recurred 2-6 times daily during the 7 months of the patient's life. After transient hypertonia hypotonia developed. In muscle biopsy specimen taken on the 51st day of life, serious and progressive distortion of mitochondria was observed. In several mitochondria the cristae structure was broken, other mitochondria were shrunken and the damage progressed towards further deterioration in other organelles. At several points between the myofibrils amorphous material was seen possible debris of destroyed mitochondria. Most myofibrils seemed to be intact; however, in some areas myolytic signs were present. Analysis of the mitochondrial DNA (mtDNA) showed multiple deletions in skeletal and heart muscles, liver, lung and kidney. Since the mtDNA encodes several proteins of the respiratory complexes, the deleted mtDNA certainly affected the integrity of the mitochondrial oxidative phosphorylation process by synthesis of abnormal proteins. In the present case the hyperthermia may have been a result of the mtDNA damage. © 1996 Wiley-Liss, Inc.     

Outcome of clavicular fracture in 89 patients

Summary During 1982, 118 patients with clavicular fracture were treated in the Department of Orthopaedics and Traumatology, Helsinki University Central Hospital. Eighty-nine patients appeared for the follow-up examination in 1984. Eighty-three fractures were treated with immobilization in a sling. Four fractures were treated with plate fixation primarily and two patients were operated on for delayed union. The immobilization averaged 21 days, range 10–42 days. The follow-up was 2 years in all cases. The result was good in 65 cases, satisfactory in 20, and poor in 4 cases. Patients with primary dislocation of more than 15 mm or with shortening observed at the follow-up examination had statistically significantly more pain than patients without these findings.

---

Zusammenfassung An der Orthopädisch-traumatologischen Klinik der Universität Helsinki wurden 1982 118 Patienten mit Klavikulafraktur behandelt. Neunundachtzig dieser Patienten konnten im Jahre 1984 nachuntersucht werden. Dreiundachtzig Frakturen waren durch Immobilisation im Armtragetuch behandelt worden. Vier Frakturen wurden primär verplattet, und zwei Fälle wurden wegen verzögerter Heilung sekundär operiert. Die Dauer der Immobilisation betrug durchschnittlich 21 Tage (10–42 Tage). Die Beobachtungszeit war in allen Fällen zwei Jahre. Das Ergebnis der Behandlung war gut in 65 Fällen, befriedigend in 20 Fällen und schlecht in 4 Fällen. Patienten mit primärer Dislokation von mehr als 15 mm oder bei der Nachuntersuchung festgestellter Verkürzung hatten signifikant mehr Schmerzen als Patienten ohne derartige Befunde.

     

2019—2020年哈密市蚊虫种类分布及携带病毒调查

目的　了解新疆维吾尔自治区哈密市蚊虫种类及病毒携带情况,并鉴定该市尖音库蚊所属亚种。方法　分别于2019、2020年7月中旬,在新疆维吾尔自治区哈密市伊州区、伊吾县、巴里坤县采用诱蚊灯法捕捉蚊虫,鉴定所捕获蚊虫种属及尖音库蚊种属。采用逆转录PCR技术检测捕获蚊虫携带黄病毒属、甲病毒属、布尼亚病毒属、流行性乙型脑炎病毒、辽宁病毒、Tahyna病毒、蜱传脑炎病毒及西尼罗病毒情况。结果　在哈密市伊州区、伊吾县、巴里坤县共捕获蚊虫1 496只,分属于3属3种。尖音库蚊为优势蚊种,占所捕获蚊虫总数的65.91%（986只）;其次为里海伊蚊,占30.55%（457只）;阿拉斯加脉毛蚊最少,仅占3.54%（53只）。所捕获尖音库蚊经雄蚊尾器鉴定为尖音库蚊指名亚种。经逆转录PCR法检测,所捕获蚊虫黄病毒属、甲病毒属、布尼亚病毒属、流行性乙型脑炎病毒、辽宁病毒、Tahyna病毒、蜱传脑炎及西尼罗病毒均为阴性。结论　2019—2020年哈密市存在尖音库蚊、里海伊蚊、阿拉斯加脉毛蚊3种蚊虫,以尖音库蚊为优势蚊种;所捕获尖音库蚊均为指名亚种,未发现蚊类携带相关虫媒病毒。     

IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis

Please cite this paper as: IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis. Experimental Dermatology 2010; 19: 648–653. Background: Patients with bullous pemphigoid (BP), mucous membrane pemphigoid (MMP) and pemphigoid gestationis (PG) have IgG antibodies against BP180 and BP230, components of the hemidesmosomes. Patients with linear IgA bullous dermatosis (LABD) have IgA autoantibodies against a 97/120‐kDa protein which is highly homologous to a shedded fragment of the BP180‐ectodomain. Objectives: The aim of our study was to determine the incidence of IgA autoantibodies directed against BP180/BP230 in the pemphigoids and LABD and to determine the antigenic regions that are targeted by IgA autoantibodies. Methods: Utilizing baculovirus‐expressed recombinant BP180 and BP230 proteins, we performed immunoblot analyses for IgA reactivity of sera from patients with BP (n = 30), MMP (n = 10), PG (n = 6), LABD (n = 6) and from control patients with non‐related pruritic dermatoses (n = 8). Results: IgA reactivity against BP180 and/or BP230 was detected in 19/30 of the BP, in 7/10 of the MMP, in 6/6 of the LABD and in 3/6 of the PG sera, respectively, but not in the control group. In all subgroups, the major antigenic site recognized by IgA antibodies was located within the NH₂‐terminus of the BP180‐ectodomain, but only a minority of the sera showed also IgA reactivity against the BP180‐NC16a‐domain. IgA reactivity against the central domain of BP180 was more frequently seen than against its COOH‐terminus. IgA against the COOH‐ and NH₂‐terminus of BP230, respectively, was detected in 6/30 of the BP, 1/10 of the MMP, 1/6 of the LABD and 0/8 control sera. Conclusion: IgA reactivity against BP180 and/or BP230 is a common finding in the pemphigoids.     

Investigation of neuromuscular blocking agents at Richter Ltd

Investigation of new neuromuscular blocking agents was started 30 years ago in Richter Ltd. This paper presents the results obtained by Richter's scientists. 2 compounds out of 100 bisquaternary ammonio steroid having androstane skeleton were selected for further pharmacological study. One of these agents, pipecuronium bromide (Arduan) elicited long-lasting block of neuromuscular transmission without cardiovascular side effects in both animal experiments and clinical studies. Arduan is a powerful competitive antagonist of acetylcholine, since it can bind pre- and postsynaptic (N1) receptors of the transmitters. It has no remarkable cumulative effect. Neostigmine rapidly and completely antagonized the neuromuscular blockade caused by pipecuronium. Arduan was introduced into clinical practice. The second compound, RGH-4201 (Duador) evoked a neuromuscular block of short duration. It showed slight atropin-like cardio-vagolytic effect in animal experiments. In the clinical studies, however, the cardiovascular side effects were found to be too strong. Therefore, it was not introduced in clinical practice.     

Inhibition of gastric emptying and small intestinal transit by ethanol is mediated by capsaicin-sensitive afferent nerves

The neural mechanisms involved in mediation of the inhibitory effects of ethanol on the gastric emptying and the small intestinal transit were studied in adult male rats. The gastrointestinal transit was determined by measuring the amount of phenol red recovered from the stomach and small intestine after intragastric administration. Spinal and/or vagal peptidergic afferent nerves were subjected to selective denervation by chemodenervation techniques using capsaicin, a potent and specific sensory neurotoxin.Intragastric administration of a 2.5 g/kg body weight dose of ethanol resulted in inhibition of the gastric emptying and the small intestinal transit. Prior systemic treatment with capsaicin, which defunctionalizes both spinal and vagal capsaicin-sensitive afferent nerves, abolished the inhibitory effect of ethanol on the gastrointestinal transit. Similarly, selective chemodenervation of the vagal afferents by perineural capsaicin treatment completely blocked the effect of ethanol. These observations furnish evidence indicative of the involvement of capsaicin-sensitive neural pathways, and in particular vagal afferent nerves, in the mediation of the inhibitory effect of large doses of ethanol on the gastrointestinal motility.     

Differential diagnosis of acute coronary syndromes

In recent years there has been an explosion in the understanding of the complex basic mechanisms responsible for the development of acute coronary syndrome. This term is widely accepted and consistent with the common pathophysiological mechanism believed to be responsible for most cases of unstable angina and myocardial infarction, with and without ST-segment elevations. This review summarizes important recent findings, recommendations that are likely to be introduced in our present and near future clinical work. The diagnosis and differential diagnosis of acute coronary syndrome are based on clinical history, physical examination, electrocardiogram, echocardiogram, coronarogram and new serum markers of the patients. According to these findings is necessary to make risk stratification algorithm (high, intermediate and low risk patients) to integrate them into realistic management strategy.